[1]
“Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 ”, Rev Diabet Stud, vol. 13, no. 4, Aug. 2016, Accessed: Nov. 27, 2025. [Online]. Available: https://diabeticstudies.org/index.php/RDS/article/view/93